Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary (2017)
- Autor:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1097/MOL.0000000000000460
- Subjects: GENÉTICA MÉDICA; EPIDEMIOLOGIA; BIOLOGIA CELULAR; ESTUDOS RANDOMIZADOS; COLESTEROL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2017
- Source:
- Título: Current opinion in lipidology
- ISSN: 0957-9672
- Volume/Número/Paginação/Ano: v. 28, n. 6, p. 522-523, 2017
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
SANTOS FILHO, Raul Dias dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary. Current opinion in lipidology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/MOL.0000000000000460. Acesso em: 01 abr. 2026. , 2017 -
APA
Santos Filho, R. D. dos. (2017). Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary. Current opinion in lipidology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1097/MOL.0000000000000460 -
NLM
Santos Filho RD dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary [Internet]. Current opinion in lipidology. 2017 ; 28( 6): 522-523.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1097/MOL.0000000000000460 -
Vancouver
Santos Filho RD dos. Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary [Internet]. Current opinion in lipidology. 2017 ; 28( 6): 522-523.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1097/MOL.0000000000000460 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
